-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-01
ARDT:NYE- (USD)
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 12.97Change
-0.78 (-5.67)%Market Cap
USD 2.59BVolume
0.62M
N/A
Verdict
Values as of: 2025-04-01
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 12.97Change
-0.78 (-5.67)%Market Cap
USD 2.59BVolume
0.62MN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
HCA | HCA Holdings Inc |
+1.30 (+0.38%) |
USD 79.32B |
THC | Tenet Healthcare Corporation |
+3.78 (+2.83%) |
USD 12.13B |
DVA | DaVita HealthCare Partners Inc |
+2.38 (+1.57%) |
USD 11.92B |
UHS | Universal Health Services Inc |
+0.97 (+0.52%) |
USD 11.22B |
EHC | Encompass Health Corp |
+0.80 (+0.79%) |
USD 10.00B |
CHE | Chemed Corp |
-3.88 (-0.63%) |
USD 8.72B |
CON | Concentra Group Holdings Paren.. |
+0.52 (+2.36%) |
USD 2.93B |
NHC | National HealthCare Corporatio.. |
+0.18 (+0.19%) |
USD 1.90B |
AGL | agilon health Inc |
-0.01 (-0.25%) |
USD 1.67B |
GRDN | Guardian Pharmacy Services, In.. |
+0.52 (+2.48%) |
USD 1.25B |
N/A
Market Performance vs. Industry/Classification (Medical Care Facilities) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -24.06% | 7% | C- | 7% | C- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -24.06% | 7% | C- | 7% | C- | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | 2.59B | 67% | D+ | 70% | C- |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.